Description
Exp.date: 2025.12.27
MeNnus Fill
“MeNnus Fill” is a CE-certified dermal filler that features PLLA, a biocompatible agent recognized for its ability to promote collagen synthesis. This innovative product serves as a non-invasive treatment for enhancing facial volume and diminishing wrinkles, delivering safe and effective outcomes for a more youthful appearance.
Benefits of PLLA Filler
The PLLA filler offers several advantages, including long-lasting effects derived from collagen stimulation, natural-looking results, economical value in the long run, versatility to tackle various concerns, and a solid safety profile with minimal risk of side effects.
Strengths of MeNnus Fill
POINT 1 - Promotes Natural Collagen Synthesis
One of the main advantages of PLLA is its capacity to promote the body's collagen production. When injected into the dermis, PLLA microspheres stimulate fibroblast activity, leading to enhanced skin elasticity and firmness over time.
POINT 2 - Extended Results
Fillers based on PLLA yield gradual and enduring results, unlike traditional hyaluronic acid fillers. As the body metabolizes the PLLA, collagen continues to form, preserving the rejuvenating effects for an extended duration.
POINT 3 - Biodegradable and Safe
PLLA is biodegradable, breaking down into harmless byproducts within the body. Its biocompatibility means it is generally well-accepted by the body, with a low incidence of adverse effects.
POINT 4 - Multi-Purpose Application
PLLA is versatile in addressing a variety of aesthetic issues, such as fine lines, loss of facial volume, and skin laxity. It is frequently utilized in treatments like facial rejuvenation, non-surgical facelifts, and contouring procedures.
MeNnus Fill provides a reliable and efficient solution for those aiming to achieve long-lasting enhancements in skin texture and overall appearance without resorting to invasive surgical methods.
General Information for Preparation
- To prepare the MeNnus Fill solution, combine one vial with 7mL of saline and 2mL of lidocaine (add the lidocaine just prior to application for optimal results).
- Allow the vial to rest for 4 hours after dilution without shaking before use.
- It should be used within 72 hours post-dilution.
- Ensure a needle size of no smaller than 23G for injections.
- If clogging occurs while administering the treatment, promptly change the needle.
Each injection of MeNnus Fill should be limited to a maximum volume of 0.1ml to 0.2ml, with injections spaced 0.5-1cm apart to avoid overcorrection.
In clinical settings, it is standard practice to assess patients at 4 to 6 weeks following treatment.
.png)
